Skip Navigation

Leadership: John A. Grosso, Ph.D. Vice President of Chemistry, Manufacturing, and Controls

Photo of John A. Grosso, Ph.D.

Dr. Grosso is the Vice President of Chemistry, Manufacturing, and Controls at Arvinas. He brings over 35 years of broadly diversified pharmaceutical development and manufacturing experience to the Company, having led process chemistry, analytical, and drug development functions both in large pharma and in biotech.

Prior to joining Arvinas, Dr. Grosso was Executive Director and Head of Pharmaceutical Development at Vitae Pharmaceuticals where he was responsible for API and DP development and manufacturing as well as Clinical Supply. During the two years spent at Vitae, he advanced two oral RORƴt antagonists and one LXR agonist into the clinic.

Dr. Grosso began his career with Bristol-Myers Squibb in Chemical Process R&D rising to the level of Director and site-head for PR&D over a twenty-year span. He transitioned into Analytical R&D where, as Executive Director, he was responsible for process analytical science, method development and testing for both API and DP, in addition to a number of specialty labs. He finished his tenure at BMS as Executive Director, Drug Product Science and Technology. Over his 32-year career at BMS he played a pivotal role in the development and commercialization of Monopril®, Taxol®, Eliquis®, Sprycel®, and Dapagliflozin®

Dr. Grosso earned his undergraduate degree in Chemistry at New York University, and his Ph.D. in Medicinal Chemistry at Purdue University.